Las Vegas, NV -- (SBWIRE) -- 10/18/2013 -- Beststocksondemand.com, is a financial newsletter and blog focused on shedding light on under-discovered small cap companies. Our team of professionals from various backgrounds work diligently to bring our members the best penny stock picks, stock market commentary, and news on all types of OTCBB and Pink Sheet companies, Komatsu Ltd (ADR) (OTCMKTS:KMTUY), Cellceutix Corp (OTCMKTS:CTIX), Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT), Decision Diagnostics Corp (OTCBB:DECN)
Komatsu Ltd (ADR) (OTCMKTS:KMTUY) opened the session at $24.31, remained amid the day range of $24.31 - $24.58, and closed the session at $24.57. The stock showed a positive performance of 0.80% in previous trading session. The stock gained a volume of 68,079 shares and the average volume of the stock remained 57,239shares. KOMATSU LTD. is a Japan-based company which manufactures, develops, markets and sells construction machinery and vehicles, as well as other industrial machinery. The Construction Machine and Vehicle segment provides excavation, loading, land-clearing, base course use, transporting, forestry, underground construction and resources recycle machines, industrial vehicles, foundry pieces, as well as transportation, warehouse and packing related services.
Why Should Investors Buy KMTUY After The Recent Gain? Just Go Here and Find Out
Cellceutix Corp (OTCMKTS:CTIX) traded with volume of 157,813 shares in the prior session and the average volume of the stock remained 325,827 shares. The 52 week range of the stock remained $0.77 - $2.47. The stock showed a negative movement of -2.86% and closed its session at $1.70. The market capitalization of the stock remained 172.58 million. Cellceutix Corporation is an early-stage developmental biopharmaceutical company. The Company has acquired exclusive rights to eight different pharmaceutical compound candidates that are designed for treatment of diseases which exist, or may exist in the future.
Will CTIX Bounce Back After yesterday’s Sharp Sell off? Find Out Here
Provectus Pharmaceuticals, Inc. (OTCMKTS:PVCT) exchanged 577,624 shares and the average volume remained 710,154 shares. The stock dropped -1.16% and closed the session at $0.850. The beta of the stock remained 0.81 and the EPS of the stock remained -0.10. The shares outstanding of the stock remained 128.62 million. Provectus Pharmaceuticals, Inc. is a development-stage pharmaceutical company that is primarily engaged in developing ethical pharmaceuticals for oncology and dermatology indications. The Company develops and focuses to license or market and sells its two prescription drug candidates, PV-10 and PH-10. The Company has transferred all its intellectual property related to over the counter (OTC) products and non-core technologies to its subsidiaries and designated, such subsidiaries as non-core to its primary business of developing its oncology and dermatology prescription drug candidates.
Is it the Right to Grab PVCT after the Recent Slump? Get Free Trend Analysis Here
Decision Diagnostics Corp (OTCBB:DECN) gained volume of 382,446 shares, while the average volume remained 373,325 shares. The stock decreased -9.69 % and finished the session Thursday at $0.578. The EPS of the stock remained -0.30. The one month of the stock was -11.08% and three month trend remained positive 168.84 %. Decision Diagnostics Corp. is a prescription and non-prescription diagnostics and home testing products distributor. The Company distributes brand name prescription and non-prescription diagnostics products, as well as several lines of ostomy, wound cares and post-surgery medical products. The Company through its subsidiaries, PDA Services, Inc. and Decision IT Corp. offers information technology solutions in several medical cares market channels by providing physicians with information at the point of care.
Will DECN Reach the Bottom after Yesterday’s Correction? Find Out Here
About:Best Stock on Demand
Beststocksondemand.com is an exciting online financial terminal where stock readers, traders and investors as well as market analysts can come to discover new opportunities, ideas, situations and news. Beststocksondemand.com goal is finding the most Undervalued or should we say Value Stocks or the Next Emerging Growth Stock that might be unnoticed by Wallstreet. Beststocksondemand.com is constantly searching for exceptional investment situations that can profit both investors and traders in order to grow their gains on a well balanced portfolio.
Beststocksondemand.com is also a well-respected marketing and research firm that mainly focuses on Best Stocks on Demand, Micro-Cap Stocks and Small Cap Stocks. Beststocksondemand.com uses its strategic corporate communication services to increase investor awareness of your company. We can support developing, emerging growth and deep-rooted companies in their marketing therefore creating a more dominant and operative investor alertness.
The assembled information disseminated by Beststocksondemand.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Beststocksondemand.com does expect that investors will buy and sell securities based on information assembled and presented in beststocksdaily.com. PLEASE always do your own due diligence, and consult your financial advisor.
Please read Our Full Disclaimer at: http://www.beststocksondemand.com/disclaimer.html
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)